Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

Blood

Volumn 100, Issue 7, 2002, Pages 2637-2641

  Hennig, Holger ^a   Puchta, Ines ^a   Luhm, Jürgen ^a   Schlenke, Peter ^a   Goerg, Siegfried ^a   Kirchner, Holger ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; PLASMA; POLYMERASE CHAIN REACTION; POSTTRANSFUSION HEPATITIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS LOAD; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 0036786948     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0798     Document Type: Article

References (48)

1. Brechot C, Degos F, Lugassy C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 1985;312:270-276.
2. Marcellin P, Martinot-Peignoux M, Loriot MA, et al. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med. 1990;112:227-228.
3. Kaneko S, Miller RH, Di Bisceglie AM, Feinstone SM, Hoofnagle JH, Purcell RH. Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. Gastroenterology. 1990;99:799-804.
4. Loriot MA, Marcellin P, Bismuth E, et al. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology. 1992;15:32-36.
5. Patedini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology. 1993;17:20-29.
6. Gomes SA, Yoshida CF, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol. 1996;40:133-138.
7. Hennig H, Dennin RH, Haase D, Kirchner H. [HBV-DNA positive findings in HBsAg negative blood donors and patients]. Beitr Infusionsther Transfusionsmed. 1997;34:26-30.
8. Yotsuyanagi H, Yasuda K, lino S, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology. 1998;27:1377-1382.
9. Blum HE, Offensperger WB, Waiter E, Offensperger S, Gerok W. Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection. Liver. 1988;8:307-316.
10. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;94:907.
11. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2:1104-1108.
12. Pasquetto V, Wieland S, Chisari FV. Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte-induced apoptosis. J Virol. 2000;74:9792-9796.
13. Loriot MA, Marcellin P, Walker F, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol. 1997;27:251-258.
14. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology. 1998;27:1736-1742.
15. Marusawa H, Uemoto S, Hijikata M, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology. 2000;31:488-495.
16. Marusawa H, Imoto S, Ueda Y, Chiba T. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol. 2001;36:633-636.
17. Marcellin P, Giostra E, Martinot-Peignoux M, et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology. 1991;100:1432-1434.
18. Dhedin N, Douvin C, Kuentz M, et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation. 1998;66:616-619.
19. Nordbo SA, Skaug K, Holter E, Waage A, Brinch L. Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol. 2000;65:86-87.
20. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685-1690.
21. Glück D. [Risk of HIV, HCV, and HBV transmission by blood products. Current data 1997 and 1998 - study on the epidemiology of HIV and hepatitis in blood donors in Germany]. Infusionsther Transfusionsmed. 1999;26:335-338.
22. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion. 1990;30:431-432.
23. Norder H, Hammas B, Larsen J, Skaug K, Magnius LO. Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Arch Virol Suppl. 1992;4:116-118.
24. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion. 1995;35:5-12.
25. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet. 1999;353:359-363.
26. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol. 1999;107:186-195.
27. Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion. 2000;40:143-159.
28. Sacher RA, Schreiber GB, Kleinman SH. Prevention of transfusion-transmitted hepatitis. Lancet. 2000;355:331-332.
29. Otake K, Nishioka K. Nucleic acid amplification testing of hepatitis B virus. Lancet. 2000;355:1460.
30. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 2001;80:63-71.
31. Beld M, Habibuw MR, Rebers SP, Boom R, Reesink HW. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in poolscreening systems. Transfusion. 2000;40:575-579.
32. Jongenus JM, Bovenhorst M, van der Poel CL, et al. Evaluation of automated nucleic acid extraction devices for application in HCV NAT. Transfusion. 2000;40:871-874.
33. Jilg W, Hottentrager B, Weinberger K, et al. Prevalence of markers of hepatitis B in the adult German population. J Med Virol. 2001;63:96-102.
34. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol. 2000;62:450-455.
35. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol. 2001;64:312-319.
36. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion. 2001;41:652-658.
37. Yotsuyanagi H, Yasuda K, Moriya K, et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2001;41:1093-1099.
38. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HB-cab(+), HBlgM(-) organ donors. Transplantation. 1995;59:230-234.
39. Lowell JA, Howard TK, White HM, et al. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet. 1995;345:1084-1085.
40. Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de'novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg. 1997;3:105-111.
41. Roche B, Samuel D, Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 1997;26:517-526.
42. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997;113:1668-1674.
43. Dodson SF, Issa S, Araya V, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation. 1997;64:1582-1584.
44. Uemoto S, Inomata Y, Sannomiya A, et al. Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody-positive donors. Transplant Proc. 1998;30:134-135.
45. Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion. 2001;41:329-332.
46. Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion. 2001;41:1107-1113.
47. Mei SD, Yatsuhashi H, Parquet MC, et al. Detection of HBV RNA in peripheral blood mononuclear cells in patients with and without HBsAg by reverse transcription polymerase chain reaction. Hepatol Res. 2000;18:19-28.
48. Su Q, Wang SF, Chang TE, et al. Circulating hepatitis B virus nucleic acids in chronic infection: representation of differently polyadenylated viral transcripts during progression to nonreplicative stages. Clin Cancer Res. 2001;7:2005-2015.